(Q34007882)

30 July 2017

title

Severe steroid-resistant post-infectious encephalomyelitis: general features and effects of IVIg (English)

1 reference

30 July 2017

Sabrina Ravaglia

1

1 reference

30 July 2017

Giovanni Piccolo

2

1 reference

30 July 2017

Mauro Ceroni

3

1 reference

30 July 2017

Diego Franciotta

4

1 reference

30 July 2017

Anna Pichiecchio

5

1 reference

30 July 2017

Stefano Bastianello

6

1 reference

30 July 2017

Eleonora Tavazzi

7

1 reference

30 July 2017

Lorenzo Minoli

8

1 reference

30 July 2017

Enrico Marchioni

9

1 reference

30 July 2017

language of work or name

1 reference

14 November 2007

1 reference

30 July 2017

number of pages

6

1 reference

inferred from page(s)

published in

Journal of Neurology

1 reference

30 July 2017

volume

254

1 reference

30 July 2017

issue

11

1 reference

30 July 2017

page(s)

1518-1523

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-007-0561-4

30 July 2017

exact match

0 references

cites work

Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00415-007-0561-4

Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin

21 January 2018

1 reference

12 December 2020

Responsiveness of the Scripps neurologic rating scale during a multiple sclerosis clinical trial

1 reference

12 December 2020

Immunoglobulins in acute, parainfectious, disseminated encephalo-myelitis

1 reference

12 December 2020

Outcome of severe encephalomyelitis in children: effect of high-dose methylprednisolone and immunoglobulins

1 reference

12 December 2020

Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis

1 reference

12 December 2020

Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis.

1 reference

12 December 2020

Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis.

1 reference

12 December 2020

A case of acute disseminated encephalomyelitis (ADEM) associated with demyelinating peripheral neuropathy

1 reference

12 December 2020

1 reference

12 December 2020

Acute disseminated encephalomyelitis: an update

1 reference

12 December 2020

Medical and surgical management of acute disseminated encephalomyelitis.

1 reference

12 December 2020

Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis

1 reference

12 December 2020

Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis

1 reference

12 December 2020

Acute transverse myelitis. A localized form of postinfectious encephalomyelitis.

1 reference

12 December 2020

A patient of ADEM with central and peripheral conduction block improved with ultra-high-dose methylprednisolone

1 reference

12 December 2020

Acute disseminated encephalomyelitis in children

1 reference

12 December 2020

Plasmapheresis in fulminant acute disseminated encephalomyelitis

1 reference

12 December 2020

Neurologic impairment in multiple sclerosis and the disability status scale.

1 reference

12 December 2020

Acute severe combined demyelination

1 reference

12 December 2020

Postinfectious encephalomyelitis

1 reference

12 December 2020

Postinfectious inflammatory disorders: subgroups based on prospective follow-up.

1 reference

12 December 2020

10.1007/S00415-007-0561-4

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1024676563

0 references

1 reference